Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 8/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.61 |
| ▸ | RAB9A | P51151 | 4/20 | 0.61 |
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.61 |
| ▸ | NPC1 | O15118 | 3/20 | 0.61 |
| ▸ | CASP3 | P42574 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.61 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.61 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | BCHE | P06276 | 3/20 | 0.57 |
| ▸ | MAOB | P27338 | 2/20 | 0.57 |
| ▸ | ACHE | P22303 | 2/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | PLIN1 | O60240 | 1/20 | 0.57 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.57 |
| ▸ | RECQL | P46063 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25194276 | 1.00 | MAPT (0.61) | MAPTKMT2ARAB9ACYP1B1NPC1 | |
| SCHEMBL15218411 | 0.89 | MAPT (0.56) | MAPTKMT2ARAB9ACYP1B1NPC1 | |
| SCHEMBL15218396 | 0.88 | MAPT (0.65) | MAPTKMT2ARAB9ACYP1B1NPC1 | |
| SCHEMBL25194492 | 0.86 | MAOB (0.59) | MAPTKMT2ARAB9ACYP1B1NPC1 | |
| SCHEMBL25197170 | 0.86 | MAOB (0.59) | MAPTKMT2ARAB9ACYP1B1NPC1 | |
| SCHEMBL15216642 | 0.86 | MAPT (0.56) | MAPTKMT2ARAB9ACYP1B1NPC1 | |
| SCHEMBL25190663 | 0.86 | MAPT (0.71) | MAPTKMT2ARAB9ACYP1B1NPC1 | |
| SCHEMBL25195905 | 0.86 | MAPT (0.71) | MAPTKMT2ARAB9ACYP1B1NPC1 | |
| SCHEMBL25207425 | 0.86 | MAPT (0.56) | MAPTKMT2ARAB9ACYP1B1NPC1 | |
| SCHEMBL15218447 | 0.86 | MAPT (0.55) | MAPTKMT2ARAB9ACYP1B1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230190679-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2023-06-22 | — | — | US | disclosed |
| WO-2023086388-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2023-05-19 | — | — | WO | disclosed |
| US-8871976-B2 | Chalcone structure fluorescence dye for embryonic stem cell probe | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2014-10-28 | — | — | US | disclosed |
| US-20130224790-A1 | Chalcone Structure Fluorescence Dye For Embryonic Stem Cell Probe | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2013-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230190679-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | SERPINC1, SERPINE1, SERPINH1 | MAPT 3512/4885KMT2A 3188/4885RAB9A 1327/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.